Avastin® (bevacizumab) Treatment for mCRC, NSCLC, mBC and mRCC in Combination with Chemotherapy

Educational Webcast

Educational Webcast

Prof Dirk Arnold discusses challenges in the treatment of mCRC

Avastin front-line in advance ovarian cancer

Click here to find out more

More
Educational webcast

Avastin front-line in women with advanced ovarian cancer

Prof Antonio González Martín
Spain

More
Controlling angiogenesis to control tumour growth

Avastin precisely targets VEGF to inhibit angiogenesis for continuous tumour control

More

Expert perspectives in colorectal cancer

Impact of Avastin in CRC

Prof Eric van Cutsem
Belgium

More
Patient case

A patient with centrally located adenocarcinoma of the lung

Dr Martin Reck
Germany

More
Expert perspectives

Importance of prolonging life

Prof Manuela Schmidinger
Austria

More

<>

Resources
Webcasts
Patient Cases

Expert perspective
Importance of prolonging life (Prof Manuela Schmidinger)
View
Controlling angiogenesis to control tumour growth
Avastin precisely targets VEGF to inhibit angiogenesis for continuous tumour control
View
Expert perspectives in CRC
Impact of Avastin in CRC (Prof Eric van Cutsem)
View

Maximising survival in NSCLC
Anti-angiogenic therapy in NSCLC: real-life perspectives (Prof Jürgen Wolf)
View
Clinical endpoints in oncology
A discussion of clinical trial endpoints used in oncology trials and how these translate into patient benefit (Dr Artur Katz)
View
Inhibiting angiogenesis
Inhibiting angiogenesis: a mechanistic evaluation (Prof Román Pérez‐Soler)
View

NSCLC patient case
A patient with adenocarcinoma of the lung and pre-existing hypertension (Dr Monika Serke)
View
CRC patient case
A patient with rectal adenocarcinoma and unresectable liver metastases (Prof Michel Ducreux)
View
NSCLC patient case
A patient who contacted her GP after experiencing pain in her lower right arm (Dr Martin Reck)
View

Upcoming Conferences

GU Cancers Symposium
,
San Francisco, CA, USA

2-4 February 2012
EAU
,
Paris, France

24-28 February 2012
EBCC
,
Vienna, Austria

21-24 March 2012

More upcoming conferences

AVASTIN INDICATIONS

USEFUL AVASTIN RESOURCES

GET MORE INFORMATION ABOUT AVASTIN

Disclaimer: Avastin.net is a comprehensive resource for healthcare professionals outside the US. If you are a US resident please visit www.avastin.com. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

You are now leaving the www.avastin.net website. Links to all external sites are provided as a resource to our visitors. Hoffmann-La Roche Inc. ("Roche") accepts no responsibility for the content of these sites. Roche does not control these sites, and the opinions, claims, or comments expressed on these sites should not be attributed to Roche, except where indicated. We recommend that you consult with your physician or other healthcare provider to obtain more information about any Roche prescription medication.